GV
VisionaryFDocument history
Earnings documents stored for GV.
Investor releaseQuarter not tagged2026-01-21CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending
GlobeNewswire
CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending
TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "CORRECTION – Visionary Holdings Inc." on Tuesday, January 13th by Visionary Holdings Inc. (Nasdaq: GV), please be advised there was an error in the attached Form 20-F PDF. The corrected release with the corrected attachment follows: Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced the public release of its final annual report and audited financial statements for the fiscal year ended March 31, 2025. The Company has completed its audited financial statements and finalized its annual report; however, the Company’s Annual Report on Form 20-F has not yet been filed with the U.S. Securities and Exchange Commission (the “SEC”). During the reporting period, the Company continued to advance its transition from a traditional education- and real estate-focused business toward a diversified platform centered on health management, anti-aging and premium medical aesthetics, complemented by its AI-enabled education business. Emerging health-related businesses generated initial revenue contributions during the fiscal year, representing early progress in the Company’s strategic repositioning and providing potential new growth avenues over the medium to long term. A copy of the Company’s final annual report, including its audited financial statements, is included as an attachment to this press release for informational purposes only. This document does not constitute a filing with the SEC. The Company intends to file its Annual Report on Form 20-F with the SEC following completion of applicable regulatory and procedural requirements. Financial Highlights For fiscal year 2025, total revenue was USD 5.04 million, representing a year-over-year decrease of 46.2%, primarily attributable to the contraction of real estate leasing operations and changes in the education policy environment. Revenue composition included: Real estate leasing revenue of USD 2.80 million Education services revenue of USD 1.18 million Life sciences and health-related businesses, including health management, anti-aging, and medical aesthetics-related products and service-based offer...
Investor releaseQuarter not tagged2026-01-13Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report
GlobeNewswire
Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report
Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced the disclosure of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025, outlining the Company’s strategic transformation, business restructuring progress, and financial performance. During the reporting period, the Company continued to advance its transition from a traditional education- and real estate-focused business toward a diversified platform centered on health management, anti-aging and premium medical aesthetics, complemented by its AI-enabled education business. Emerging health-related businesses generated initial revenue contributions during the fiscal year, representing early progress in the Company’s strategic repositioning and providing potential new growth avenues over the medium to long term. The complete and official Annual Report on Form 20-F is included as an attachment to this press release. Financial Highlights For fiscal year 2025, total revenue was USD 5.04 million, representing a year-over-year decrease of 46.2%, primarily attributable to the contraction of real estate leasing operations and changes in the education policy environment. Revenue composition included: Real estate leasing revenue of USD 2.80 million Education services revenue of USD 1.18 million Life sciences and health-related businesses, including health management, anti-aging, and medical aesthetics-related products and service-based offerings, generating USD 1.06 million Revenue from emerging businesses accounted for approximately 21.1% of total revenue, indicating that the Company’s business restructuring has entered an early implementation stage. The Company reported a net loss of USD 15.75 million, primarily reflecting one-time transformation-related investments, approximately USD 4.70 million in asset impairment charges, and financing-related costs, which management considers to be transitional in nature. Gross margin improved modestly to 28.0%, with the education services segment achieving a gross margin of 64.4%, demonstrating relative stability in core operating efficiency. Cash flow from investing activities totaled USD 14.51 million, mainly resulting from asset dispositions that supported liquidity during the transformation period. Op...

